title: [Conservative treatment of echinococcus alveolaris of the liver: preliminary observations (author's transl)].
abstract: Mebendazol (Vermox) was given for six months at an oral daily dose of 2 g to three patients with inoperable infestation of the liver by Echinococcus alveolaris. In two patients the general state improved greatly, with reduction in the size of the liver infiltrate, regression in serum bilirubin and alkaline phosphatase levels. Treatment continues in the third case.
mesh_terms: D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001562:Benzimidazoles / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D004444:Echinococcosis, Hepatic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008463:Mebendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D010166:Palliative Care
chemical_list: D001562:Benzimidazoles; D008463:Mebendazole; D000469:Alkaline Phosphatase; D001663:Bilirubin
vernacular_title: Die konservative Behandlung des Echinococcus alveolaris der Leber. Vorläufige Mitteilung.